Discontinued — last reported Q4 '19
Products & Services · Payment For Product Development
Treprostinil — Payment For Product Development
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2019
Last reportedQ4 2019
How to read this metric
Higher spending may signal aggressive investment in product lifecycle or new indications, whereas lower spending could indicate a shift toward harvesting existing market share or reduced R&D activity.
Detailed definition
This metric captures the actual cash expenditures or accrued costs specifically allocated to the research, clinical tria...
Peer comparison
Comparable to R&D expense allocations by product or therapeutic area found in the segment reporting of major pharmaceutical and biotechnology firms.
Metric ID:
uthr_segment_treprostinil_payment_for_product_developmentSimilar Metrics at Other Companies
Frequently Asked Questions
- What does treprostinil — payment for product development mean?
- The amount of money spent on research, testing, and regulatory activities to develop or improve a specific product.